IPO Trending
APPLSME / BSEListed

Aptus Pharma Limited

Aptus Pharma Ltd, incorporated in 2010, is engaged in the marketing and distribution of finished pharmaceutical formulations. The company manufactures and distributes a wide range of products across multiple therapeutic areas including antacids and PPIs, pain management, anti-inflammatories, antibiotics, cardiology and antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, and sachets. Its business divisions include Aptus Pharma, which focuses on acute therapies such as anti-infectives and pain management; Aptus CD Care, which specializes in chronic therapies; Aptus Wellcare, which offers wellness and nutraceutical products; and Aptus Global, which caters to the export market. As of March 31, 2025, the company had developed 194 pharmaceutical formulations across more than eleven therapeutic segments. It operates warehouses covering 15,732 sq. feet and 1,989 sq. feet in Ahmedabad, Gujarat. The company’s distribution network consists of 125 direct and sub-distributors supported by a sales team of 54 field personnel, and it employed 70 people as of March 31, 2025.

₹65 - ₹7021.48x sub
Listed Price82.00
Listing Gain+17.14%
TimelineBookbuilding IPO
Open23 Sep 2025
Close25 Sep 2025
Allotment26 Sep 2025
Listing30 Sep 2025

Quota Reservation Portions

AnchorPortion: 5,28,000 shares
28.39%
QIBPortion: 3,52,000 shares
18.92%
HNIPortion: 2,66,000 shares
14.3%
RetailPortion: 6,20,000 shares
33.33%
Market MakerPortion: 94,000 shares
5.05%

Minimum Application Bracket Matrix

Retail2 lots / 4,000 shares
₹2,80,000
sHNI3 lots / 6,000 shares
₹4,20,000
bHNI8 lots / 16,000 shares
₹11,20,000

About the Company

Aptus Pharma Ltd, incorporated in 2010, is engaged in the marketing and distribution of finished pharmaceutical formulations. The company manufactures and distributes a wide range of products across multiple therapeutic areas including antacids and PPIs, pain management, anti-inflammatories, antibiotics, cardiology and antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, and sachets. Its business divisions include Aptus Pharma, which focuses on acute therapies such as anti-infectives and pain management; Aptus CD Care, which specializes in chronic therapies; Aptus Wellcare, which offers wellness and nutraceutical products; and Aptus Global, which caters to the export market. As of March 31, 2025, the company had developed 194 pharmaceutical formulations across more than eleven therapeutic segments. It operates warehouses covering 15,732 sq. feet and 1,989 sq. feet in Ahmedabad, Gujarat. The company’s distribution network consists of 125 direct and sub-distributors supported by a sales team of 54 field personnel, and it employed 70 people as of March 31, 2025.

Company Promoters

Tejash Maheshchandra HathiChatrabhuj Vallabhbhai ButaniKapilbhai Hasmukhbhai ChandaranaGhanshyam Vinubhai PansuriyaMilly Chetan LalsetaRiddhish Natwarlal TannaGaurang Rameshchandra ThakkerKripaliben Mayank ThakkerKunjal Piyushbhai Unadkat
Aptus Pharma Limited IPO Details | GMP, Allotment & Financials | IPO Trending